{"id":98,"date":"2026-02-12T12:18:21","date_gmt":"2026-02-12T11:18:21","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/?page_id=98"},"modified":"2026-11-12T13:16:21","modified_gmt":"2026-11-12T12:16:21","slug":"miercoles-20-de-enero","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/programa\/miercoles-20-de-enero\/","title":{"rendered":"Mi\u00e9rcoles, 20 de enero"},"content":{"rendered":"<div class=\"program-containers\">\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">10:15 &#8211; 10:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Bienvenida y resumen aportaciones GEICAM en SABCS<\/span>\r\n<!--<div class=\"ponentes-sesion\"><span class=\"ponente\">Nombre Apellido<\/span>\r\n<span class=\"sede\">Hospital General Universitario Gregorio Mara\u00f1on<\/span><\/div>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Nombre Apellido<\/span>\r\n<span class=\"sede\">Hospital General Universitario Gregorio Mara\u00f1on<\/span><\/div>-->\r\n<\/div>\r\n<\/div>\r\n<div class=\"sessions-titles\">\r\n<div class=\"left-column\">10:15 &#8211; 11:20<\/div>\r\n<div class=\"title-right-column\"><strong>SESI\u00d3N I:<\/strong> NUEVOS HORIZONTES: METABOLISMO, \r\nVACUNAS E INELIGENCIA ARTIFICIAL<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column moderators\">Moderan:<\/div>\r\n<div class=\"right-column\">\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Ram\u00f3n Colomer,<\/span>\r\n<span class=\"sede\">Hospital Univ. de La Princesa, Madrid<\/span><\/div>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Luis de la Cruz,<\/span>\r\n<span class=\"sede\">Hospital Univ. Virgen Macarena, Sevilla<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">10:15 &#8211; 10:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Obesidad y agonistas de GLP-1: del factor de riesgo\r\na la diana terap\u00e9utica en c\u00e1ncer de mama<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Fiorella X. Palmas<\/span>\r\n<span class=\"sede\">Hospital Universitario Vall Hebron, Barcelona<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">10:30 &#8211; 10:45<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Aprovechando el sistema inmunitario para la \r\nprevenci\u00f3n y tratamiento del c\u00e1ncer de mama:\r\nnuevas vacuna<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Marta Santisteban<\/span>\r\n<span class=\"sede\">Cl\u00ednica Univ. de Navarra, Pamplona<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">10:45 &#8211; 11:00<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Inteligencia artificial en patolog\u00eda mamaria:\r\ndel diagn\u00f3stico digital a la predicci\u00f3n\r\nde biomarcadores<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Laura Comerma,<\/span>\r\n<span class=\"sede\">Hospital del Mar, Barcelona<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">11:00 &#8211; 11:20<\/div>\r\n<div class=\"right-column\">\r\n<span class=\"titulo-ponencia\">Debate<\/span>\r\n<\/div>\r\n<\/div>\r\n<br>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">11:20-11:50<\/div>\r\n<div class=\"right-column\">\r\n<span class=\"titulo-ponencia\" style=\"color:var(--color_2);\">Pausa caf\u00e9<\/span>\r\n<\/div>\r\n<br>\r\n<\/div>\r\n<div class=\"sessions-titles\">\r\n<div class=\"left-column\">11:50 &#8211; 13:00<\/div>\r\n<div class=\"title-right-column\"><strong>SESI\u00d3N II:<\/strong> BIOMARCADORES EN LA TOMA\r\nDE DECISIONES: ENFERMEDAD PRECOZ\r\nY AVANZADA<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column moderators\">Moderan:<\/div>\r\n<div class=\"right-column\">\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Francisco Ayala,<\/span>\r\n<span class=\"sede\">Hospital General Univ. Gregorio Mara\u00f1\u00f3n, Madrid<\/span><\/div>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Juan de la Haba,<\/span>\r\n<span class=\"sede\">Hospital Univ. Reina Sof\u00eda, C\u00f3rdoba<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">11:50 &#8211; 12:25<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Tumor Board de enfermedad precoz: gen\u00f3mica y \r\nmonitorizaci\u00f3n din\u00e1mica para escalar y desescalar \r\nel tratamiento<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Javier Pascual,<\/span>\r\n<span class=\"sede\">Hospital Univ. Virgen de la Victoria, M\u00e1laga<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">12:25 &#8211; 13:00<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Tumor Board de enfermedad avanzada: \r\nbiomarcadores accionables y nuevos f\u00e1rmacos\r\nen la pr\u00e1ctica cl\u00ednica<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Alfonso L\u00f3pez de S\u00e1,<\/span>\r\n<span class=\"sede\">Hospital Cl\u00ednico San Carlos, Madrid<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<\/div>\r\n\r\n<div class=\"program-containers\">\r\n<div class=\"sessions-titles\">\r\n<div class=\"left-column\">13:00 &#8211; 14:00<\/div>\r\n<div class=\"title-right-column\"><strong>SESI\u00d3N III:<\/strong> ABORDAJE MULTDISCIPLINAR\r\nE INDIVIDUALIZACI\u00d3N TERAP\u00c9UTICA\r\nEN EL C\u00c1NCER DE MAMA<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column moderators\">Moderan:<\/div>\r\n<div class=\"right-column\">\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Agust\u00ed Barnadas,<\/span>\r\n<span class=\"sede\">Hospital de la Santa Creu i Sant Pau, Barcelona\r\n<\/span><\/div>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Mar\u00eda del Mar Vernet,<\/span>\r\n<span class=\"sede\">Hospital del Mar, Barcelona\r\n<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">13:00 &#8211; 13:15<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Radiolog\u00eda en la individualizaci\u00f3n del tratamiento: \r\ndel diagn\u00f3stico a la valoraci\u00f3n de respuesta\r\ny las terapias m\u00ednimamente invasivas<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Luc\u00eda Gra\u00f1a L\u00f3pez,<\/span>\r\n<span class=\"sede\">Hospital Univ. Lucus Augusti, Lugo<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">13:15 &#8211; 13:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Tratamiento locorregional individualizado: cirug\u00eda \r\ny radioterapia en busca del equilibrio entre control \r\nde la enfermedad y desescalada<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Carolina de la Pinta,<\/span>\r\n<span class=\"sede\">Hospital Univ. Ram\u00f3n y Cajal, Madrid<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">13:30 &#8211; 13:45<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Terapia endocrina neoadyuvante y exclusiva en \r\nc\u00e1ncer de mama precoz: \u00bfa qui\u00e9n podemos evitar \r\nla quimioterapia o la cirug\u00eda?<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dr. Miguel Gil-Gil,<\/span>\r\n<span class=\"sede\">Institut Catal\u00e0 d&#8217;Oncologia (ICO) L&#8217;Hospitalet, \r\nBarcelona\r\n<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">13:45 &#8211; 14:00<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Debate<\/span>\r\n<\/div>\r\n<\/div>\r\n<br>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">14:00 &#8211; 15:15 <\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\" style=\"color:var(--color_2);\">Almuerzo<\/span>\r\n<\/div>\r\n<\/div>\r\n<br>\r\n<div class=\"sessions-titles\">\r\n<div class=\"left-column\">15:15 &#8211; 16:15<\/div>\r\n<div class=\"title-right-column\"><strong>SESI\u00d3N IV:<\/strong> TRATAMIENTO SISTEM\u00c1TICO DEL C\u00c1NCER \r\nDE MAMA POR SUBIPOS DEL C\u00c1CNER\r\nDE MAMA POR SUBTIPOS: NOVEDADES\r\nE IMPLICACIONES CL\u00cdNICAS<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column moderators\">Moderan:<\/div>\r\n<div class=\"right-column\">\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Isabel \u00c1lvarez,<\/span>\r\n<span class=\"sede\">Unidad de C\u00e1ncer de Guip\u00fazcoa &#8211; Osakidetza,\r\nSan Sebasti\u00e1n\r\n<\/span><\/div>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Bego\u00f1a Bermejo,<\/span>\r\n<span class=\"sede\">Hospital Cl\u00ednico Univ. de Valencia, Valencia\r\n<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">15:15 &#8211; 15:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">C\u00e1ncer de mama luminal:\r\nnovedades e impacto en la pr\u00e1ctica cl\u00ednica<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Andrea Carolina Vethencourt,<\/span>\r\n<span class=\"sede\">Institut Catal\u00e0 d&#8217;Oncologia (ICO),\r\nBarcelona<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">15:30 &#8211; 15:45<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">C\u00e1ncer de mama HER2-positivo:\r\nnovedades e impacto en la practica cl\u00ednica<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Alicia de Luna,<\/span>\r\n<span class=\"sede\">Hospital Univ. Morales Meseguer, Murcia<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">15:45 &#8211; 16:00<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">C\u00e1ncer de mama triple negativo:\r\nnovedades e impacto en la pr\u00e1ctica cl\u00ednica<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Nerea Ancizar,<\/span>\r\n<span class=\"sede\">Hospital Univ. Donostia, San Sebasti\u00e1n\r\n<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">16:00 &#8211; 16:15<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Debate<\/span>\r\n<\/div>\r\n<\/div>\r\n<br>\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">16:15 &#8211; 16:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Presentaci\u00f3n de los resultados del proyecto de la \r\nBeca GEICAM Balil Pelegr\u00ed 2023<\/span>\r\n<div class=\"ponentes-sesion\"><span class=\"ponente\">Dra. Roser Velasco Fargas,<\/span>\r\n<span class=\"sede\">Instituto Catal\u00e1n de Oncolog\u00eda, ICO, Hospitalet<\/span><\/div>\r\n<\/div>\r\n<\/div>\r\n<br>\r\n\r\n<div class=\"ponencias-sesiones\">\r\n<div class=\"left-column\">16:30<\/div>\r\n<div class=\"right-column\">\r\n\r\n<span class=\"titulo-ponencia\">Conclusiones\r\ny cierre de la jornada<\/span>\r\n<\/div>\r\n<\/div>\r\n<\/div>","protected":false},"excerpt":{"rendered":"10:15 &#8211; 10:30 Bienvenida y resumen aportaciones GEICAM en SABCS 10:15 &#8211; 11:20 SESI\u00d3N I: NUEVOS HORIZONTES: METABOLISMO, VACUNAS E INELIGENCIA ARTIFICIAL Moderan: Dr. Ram\u00f3n Colomer, Hospital Univ. de La Princesa, Madrid Dr. Luis de la Cruz, Hospital Univ. Virgen Macarena, Sevilla 10:15 &#8211; 10:30 Obesidad y agonistas de GLP-1: del factor de riesgo a &#8230; <a title=\"Mi\u00e9rcoles, 20 de enero\" class=\"read-more\" href=\"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/programa\/miercoles-20-de-enero\/\" aria-label=\"Leer m\u00e1s sobre Mi\u00e9rcoles, 20 de enero\">Leer m\u00e1s<\/a>","protected":false},"author":2,"featured_media":0,"parent":45,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-internas.php","meta":{"footnotes":""},"class_list":["post-98","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/pages\/98","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/comments?post=98"}],"version-history":[{"count":20,"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/pages\/98\/revisions"}],"predecessor-version":[{"id":211,"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/pages\/98\/revisions\/211"}],"up":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/pages\/45"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2027\/conclusionesgeicam2027\/wp-json\/wp\/v2\/media?parent=98"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}